Peptide Therapy Due to the FDA's recent ban on the production of substances necessary for compounding pharmacies to continue manufacturing peptides, we have discontinued certain peptides from our service list
10.3389/fphar.2015.00262 30 BrigitteV.DenisG.HenriP.PourratA.BastideP.JeanineB
side effects may affect eating Percentage : Approximately 0.5-2% body weight lost for 220-pound individual Weeks 5-8 (First Dose Increase): Expected : 3-7 additional pounds lost Cumulative : 4-11 pounds total from baseline Why More Loss : Higher dose provides stronger appetite suppression Percentage : Approximately 2-5% cumulative body weight lost Weeks 9-12 (Second Dose Increase): Expected : 3-7 additional pounds lost Cumulative : 7-18 pounds total from baseline Percentage : Approximately 3-8% cumulative body weight lost Milestone : Many members notice clothing fitting differently, others commenting Months 4-6 (Continued Escalation): Expected : 1-2 pounds weekly average Cumulative : 15-30 pounds total from baseline Percentage : Approximately 7-14% cumulative body weight lost Milestone : Significant visible changes, substantial health improvements Months 7-12 (Maintenance Dose Phase): Expected : 0.5-1.5 pounds weekly average (rate slows) Cumulative : 30-45 pounds total from baseline Percentage : Approximately 14-20% cumulative body weight lost (if reaching clinical trial averages) Milestone : Major health transformations, lifestyle adaptations Beyond 12 Months : Rate typically slows significantly or plateaus Focus shifts from loss to maintenance Continued medication typically required to maintain results May achieve additional modest losses with continued treatment Important Expectations : These are averages : Individual results vary dramatically Not linear : Weight loss occurs in irregular pattern (stalls, whooshes, plateaus) Water weight fluctuations : Daily scale fluctuations 2-4 pounds normal (water, not fat) Plateaus normal : Multi-week plateaus common
By blocking central CB1 signaling, rimonabant was associated with serious psychiatric adverse effects, including anxiety, depressive symptoms, and suicidal ideation
